AMICUS THERAPEUTICS, INC. Contracts & Agreements

First Amendment to the Supply and Manufacturing Services Agreement (Filed With SEC on August 8, 2024)

Second Restated Agreement, dated November 19, 2013 by and between the Registrant and Glaxo Group Limited (Filed With SEC on February 28, 2024)

Employment Agreement, dated August 21, 2023, by and between Amicus Therapeutics, Inc. and Simon Harford (Filed With SEC on November 8, 2023)

Supply and Manufacturing Services Agreement, dated as of March 31, 2023, by and among the Company, WuXi Biologics (Hong Kong) Limited, WuXi Biologics Ireland Limited and WuXi... (Filed With SEC on August 8, 2023)

Employment Agreement dated February 18, 2020 between the Registrant and David Clark (Filed With SEC on March 1, 2023)

Employment Agreement dated February 18, 2020 between the Registrant and Jeffrey Castelli (Filed With SEC on March 1, 2023)

License Agreement dated December 22, 2022, by and between Amicus Therapeutics, Inc. and the Trustees of the University of Pennsylvania (Filed With SEC on March 1, 2023)

Mutual Termination Agreement dated December 22, 2022, by and between Amicus Therapeutics, Inc. and the Trustees of the University of Pennsylvania (Filed With SEC on March 1, 2023)

Form of Director and Officer Indemnification Agreement (Filed With SEC on December 28, 2022)

Equity Distribution Agreement, dated November 7, 2022, by and between Amicus Therapeutics, Inc. and Goldman Sachs & Co. LLC (Filed With SEC on November 7, 2022)

Employment Agreement, dated August 1, 2022, by and between the Company and Bradley L. Campbell (Filed With SEC on August 1, 2022)

Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on February 24, 2022)

Third Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 3, 2020 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)

Fourth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 23, 2020 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)

Fifth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated April 6, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)

Sixth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated August 1, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)

Seventh Amendment to the Amended and Restated Research, Collaboration & License Agreement dated September 28, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on February 24, 2022)

Termination Agreement, dated as of February 23, 2022, by and between ARYA and the Company (Filed With SEC on February 24, 2022)

Employment Agreement, dated February 23, 2022, by and between the Company and John F. Crowley (Filed With SEC on February 24, 2022)

Amendment #3 to the Amicus Therapeutics, Inc. Cash Deferral Plan (Filed With SEC on November 9, 2021)

Form of Pre-Funded Warrant (Filed With SEC on September 29, 2021)

Form of Board Restricted Stock Unit Award Agreement under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on March 1, 2021)

Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on March 1, 2021)

Form of Board Stock Option Award Agreement under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on March 1, 2021)

Form of Stock Option Award Agreement under the Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on March 1, 2021)

Notice of Non-Renewal of Lease Agreement dated August 16, 2011 between the Registrant and Cedar Brook 3 Corporate Center, L.P (Filed With SEC on August 10, 2020)

First Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 20, 2019 by and between Amicus Therapeutics, Inc. and the Trustees of the... (Filed With SEC on May 7, 2020)

Second Amendment to the Amended and Restated Research, Collaboration & License Agreement dated (Filed With SEC on May 7, 2020)

Description of the Registrant's securities (Filed With SEC on March 2, 2020)

Amendment No. 1 to Employment Agreement dated April 23, 2014 between the Registrant and John F. Crowley (Filed With SEC on March 2, 2020)

Employment Agreement dated February 18, 2020, between the Registrant and Ellen S. Rosenberg (Filed With SEC on March 2, 2020)

Employment Agreement dated February 18, 2020, between the Registrant and Bradley L. Campbell (Filed With SEC on March 2, 2020)

Employment Agreement dated February 18, 2020, between the Registrant and Jay Barth, M.D (Filed With SEC on March 2, 2020)

Employment Agreement dated February 18, 2020, between the Registrant and Daphne Quimi (Filed With SEC on March 2, 2020)

Employment Agreement dated February 18, 2020 between the Registrant and Hung Do (Filed With SEC on March 2, 2020)

Amendment #2 to the Amicus Therapeutics, Inc. Cash Deferral Plan (Filed With SEC on December 19, 2019)

Form of Capped Call Transaction Termination Agreement (Filed With SEC on August 8, 2019)

Amended and Restated Research, Collaboration & License Agreement, dated May 28, 2019, by and between Amicus Therapeutics, Inc. and the Trustees of the University of Pennsylvania (Filed With SEC on August 8, 2019)

Form of Exchange Agreement Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on June 19, 2019)

Underwriting Agreement, dated May 30, 2019, by and among Amicus Therapeutics, Inc., J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and SVB Leerink LLC (Filed With SEC on May 31, 2019)

Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on May 22, 2019)

Form of Call Option Partial Termination Agreement (Filed With SEC on May 9, 2019)

Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on March 13, 2019)

Research, Collaboration and License Agreement with The Trustees of the University of Pennsylvania dated October 8, 2018 (Filed With SEC on February 28, 2019)

Separation Agreement with William D. Baird III dated as of February 8, 2019 (Filed With SEC on February 28, 2019)

Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on February 8, 2019)

Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on January 24, 2019)

Agreement and Plan of Merger, dated as of September 19, 2018, by and among Amicus Therapeutics, Inc., Columbus Merger Sub Corp., Celenex, Inc. and Shareholder Representative... (Filed With SEC on September 25, 2018)

Amended and Restated 2007 Equity Incentive Plan (Filed With SEC on June 8, 2018)

Underwriting Agreement dated February 15, 2018, by and among Amicus Therapeutics, Inc., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several... (Filed With SEC on February 16, 2018)

Amended and Restated Amicus Therapeutics, Inc. Restricted Stock Unit Deferral Plan (Filed With SEC on December 28, 2017)

AMICUS THERAPEUTICS, INC. 18,367,347 Shares of Common Stock, Par Value $0.01 per Share Underwriting Agreement (Filed With SEC on July 13, 2017)

RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN (Filed With SEC on December 30, 2016)

AMICUS THERAPEUTICS, INC. (Company) WILMINGTON TRUST, NATIONAL ASSOCIATION (Trustee) 3.00% Convertible Senior Notes due 2023 INDENTURE Dated as of December 21, 2016 (Filed With SEC on December 21, 2016)

GOLDMAN, SACHS & CO. | 200 WEST STREET | NEW YORK, NEW YORK 10282-2198 | TEL: 212 ###-###-#### (Filed With SEC on December 21, 2016)

JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on December 21, 2016)

GOLDMAN, SACHS & CO. | 200 WEST STREET | NEW YORK, NEW YORK 10282-2198 | TEL: 212 ###-###-#### (Filed With SEC on December 21, 2016)

JPMorgan Chase Bank, National Association Organised under the laws of the United States as a National Banking Association. Main Office 1111 Polaris Parkway, Columbus, Ohio 43240... (Filed With SEC on December 21, 2016)

NOTE PURCHASE AGREEMENT (Filed With SEC on December 21, 2016)

AMICUS THERAPEUTICS, INC. CASH DEFERRAL PLAN (Filed With SEC on October 28, 2016)

AMENDMENT NO. 1 TO THE AMENDED AND RESTATED AMICUS THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN (Filed With SEC on July 29, 2016)

AGREEMENT AND PLAN OF MERGER by and among MIAMED, INC., AMICUS THERAPEUTICS, INC., MINERVAS MERGER SUB, INC. and MM STOCKHOLDERS REPRESENTATIVE LLC, solely in its capacity as the... (Filed With SEC on July 6, 2016)

FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on July 1, 2016)

JOINDER TO AND AMENDMENT OF NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on July 1, 2016)

AMENDED AND RESTATED AMICUS THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN (Filed With SEC on June 13, 2016)

Management Bonus Program Summary (Filed With SEC on June 9, 2016)

1 Cedarbrook Drive, Cranbury, NJ 08512 ###-###-#### www.amicusrx.com (Filed With SEC on March 15, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on February 29, 2016)

AMICUS THERAPEUTICS, INC. $100,000,000 OF SHARES COMMON STOCK (PAR VALUE $0.01 PER SHARE) SALES AGREEMENT (Filed With SEC on February 26, 2016)

Exhibit C FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on February 22, 2016)

NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on February 22, 2016)

FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on October 1, 2015)

NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on October 1, 2015)

AMENDMENT TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on September 30, 2015)

FIRST AMENDMENT TO LEASE (Filed With SEC on September 14, 2015)

AGREEMENT AND PLAN OF MERGER BY AND AMONG AMICUS THERAPEUTICS, INC., TITAN MERGER SUB CORP., SCIODERM, INC. AND FORTIS ADVISORS LLC, AS SHAREHOLDERS AGENT AUGUST 30, 2015 (Filed With SEC on September 3, 2015)

AMICUS THERAPEUTICS, INC. 16,981,132 Shares of Common Stock, Par Value $0.01 per Share Underwriting Agreement (Filed With SEC on June 12, 2015)

FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENT (Filed With SEC on April 28, 2015)

AMICUS THERAPEUTICS, INC. 13,850,000 Shares of Common Stock, Par Value $0.01 Per Share Underwriting Agreement (Filed With SEC on November 24, 2014)

AMENDMENT NO. 1 TO THE AMICUS THERAPEUTICS, INC. CASH DEFERRAL PLAN (Filed With SEC on October 16, 2014)

LETTER AGREEMENT (Filed With SEC on August 7, 2014)

AMICUS THERAPEUTICS, INC. CASH DEFERRAL PLAN (Filed With SEC on July 2, 2014)

AMENDED AND RESTATED AMICUS THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN (Filed With SEC on June 23, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on May 5, 2014)

LETTER AGREEMENT (Filed With SEC on May 5, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on April 25, 2014)

AMICUS THERAPEUTICS, INC. RESTRICTED STOCK UNIT DEFERRAL PLAN (Filed With SEC on April 10, 2014)

RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN (Filed With SEC on April 10, 2014)

AMICUS THERAPEUTICS, INC. $40,000,000 OF SHARES COMMON STOCK (PAR VALUE $0.01 PER SHARE) SALES AGREEMENT (Filed With SEC on March 4, 2014)

Management Bonus Program (Filed With SEC on March 3, 2014)

SECOND RESTATED AGREEMENT (Filed With SEC on March 3, 2014)

AGREEMENT AND PLAN OF MERGER by and among AMICUS THERAPEUTICS, INC., CB ACQUISITION CORP., CALLIDUS BIOPHARMA, INC. and CUONG DO, AS HOLDER REPRESENTATIVE Dated as of November 19,... (Filed With SEC on February 12, 2014)

Schedule A Stock Options Expiration Schedule (Filed With SEC on January 8, 2014)

Credit and Security Agreement CREDIT AND SECURITY AGREEMENT (Filed With SEC on December 30, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 21, 2013)

FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on November 21, 2013)

LETTER AGREEMENT (Filed With SEC on August 7, 2013)

Second Amendment to Lease (Filed With SEC on May 22, 2013)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 24, 2013)

1 Cedar Brook Drive Cranbury, NJ 08512 T: 609 ###-###-#### F: 609 ###-###-#### www.amicusrx.com (Filed With SEC on April 24, 2013)

/s/ William D. Baird (Filed With SEC on April 16, 2012)

AMICUS THERAPEUTICS, INC. (a Delaware corporation) 10,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 2, 2012)

First Amendment to Lease (Filed With SEC on February 28, 2012)

L E A S E A G R E E M E N T (Filed With SEC on August 16, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on June 30, 2011)

AMENDED AND RESTATED AMICUS THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN (Filed With SEC on May 25, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on April 18, 2011)

LETTER AGREEMENT (Filed With SEC on April 18, 2011)

RESTRICTED STOCK AWARD AGREEMENT UNDER THE AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN (Filed With SEC on April 18, 2011)

the progress and results of our clinical trials of our drug candidates, including Amigal (Filed With SEC on March 4, 2011)

2010 AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 21, 2010)

AMENDED AND RESTATED AMICUS THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN (Filed With SEC on June 18, 2010)

AMENDED AND RESTATED AMICUS THERAPEUTICS 2007 DIRECTOR OPTION PLAN (Filed With SEC on June 18, 2010)

the progress and results of our clinical trials of our drug candidates, including Amigal (Filed With SEC on May 7, 2010)

Form of Warrant to Purchase Common Stock AMICUS THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK To Purchase __________________ Shares of Common Stock (Filed With SEC on February 26, 2010)

Form of (Filed With SEC on February 26, 2010)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on February 26, 2010)

MUTUAL TERMINATION AGREEMENT (Filed With SEC on October 29, 2009)

our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220 (Filed With SEC on August 6, 2009)

our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220 (Filed With SEC on May 8, 2009)

our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220 (Filed With SEC on February 6, 2009)

EX-10.1 2008 Amended and Restated Employment Agreement dated December 30, 2008 (Filed With SEC on December 31, 2008)

EX-10.2 Letter Agreement dated December 30, 2008 between Amicus Therapeutics, Inc. and James E. Dentzer (Filed With SEC on December 31, 2008)

EX-10.3 Letter Agreement dated December 30, 2008 between Amicus Therapeutics, Inc. and Matthew Patterson (Filed With SEC on December 31, 2008)

EX-10.4 Letter Agreement dated December 30, 2008 between Amicus Therapeutics, Inc. and David Lockhart (Filed With SEC on December 31, 2008)

EX-10.5 Letter Agreement dated December 30, 2008 between Amicus Therapeutics, Inc. and Gregory Licholai (Filed With SEC on December 31, 2008)

our plans to develop, seek regulatory approval for and commercialize Amigal, Plicera and AT2220 (Filed With SEC on November 4, 2008)

AMENDED AND RESTATED AMICUS THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN (Filed With SEC on June 12, 2008)

LETTER AGREEMENT (Filed With SEC on June 12, 2008)

AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (John F. Crowley) (Filed With SEC on February 11, 2008)

License and Collaboration Agreement (Filed With SEC on February 8, 2008)

Severance and Change in Control Agreement, David Lockhart, Ph.D (Filed With SEC on November 13, 2007)

Severance and Change in Control Agreement, James E. Dentzer (Filed With SEC on November 13, 2007)

Severance and Change in Control Agreement, Matthew R. Patterson (Filed With SEC on November 13, 2007)

Severance and Change in Control Agreement, David Palling, Ph.D (Filed With SEC on November 13, 2007)

Severance and Change in Control Agreement, Douglas A. Branch (Filed With SEC on November 13, 2007)

Severance and Change in Control Agreement, Bradley L. Campbell (Filed With SEC on November 13, 2007)

Severance and Change in Control Agreement, Gregory P. Licholai, M.D (Filed With SEC on November 13, 2007)

Severance and Change in Control Agreement, Mark Simon (Filed With SEC on November 13, 2007)

Severance and Change in Control Agreement, S. Nicole Schaeffer (Filed With SEC on November 13, 2007)

EX-1.1: FORM OF UNDERWRITING AGREEMENT (Filed With SEC on May 17, 2007)

EX-4.1: SPECIMEN STOCK CERTIFICATE (Filed With SEC on May 17, 2007)

EX-10.2: 2007 EQUITY INCENTIVE PLAN AND FORMS OF OPTION AGREEMENTS (Filed With SEC on May 17, 2007)

EX-10.23: 2007 DIRECTOR OPTION PLAN AND FORM OF OPTION AGREEMENT (Filed With SEC on May 17, 2007)

EX-10.24: 2007 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 17, 2007)

EX-10.25: SEVERANCE AND CHANGE IN CONTROL AGREEMENTS (Filed With SEC on May 17, 2007)

EX-10.1: 2002 EQUITY INCENTIVE PLAN AS AMENDED, AND FORMS OF OPTION AGREEMENTS (Filed With SEC on April 27, 2007)

EX-10.19: EMPLOYMENT AGREEMENT WITH DONALD J. HAYDEN, JR (Filed With SEC on April 27, 2007)

EX-10.20: RESTRICTED STOCK AGREEMENT (Filed With SEC on April 27, 2007)

EX-10.21: RESTRICTED STOCK AGREEMENT (Filed With SEC on April 27, 2007)

EX-10.22: LEASE AGREEMENT,DATED JULY 31, 2006 (Filed With SEC on April 27, 2007)

EX-4.2: THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on March 30, 2007)

EX-4.3: WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on March 30, 2007)

EX-10.1: 2002 EQUITY INCENTIVE PLAN, AS AMENDED (Filed With SEC on March 30, 2007)

EX-10.3: LICENSE AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.4: LICENSE AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.5: EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.6: SUBLEASE AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.7: AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.8: LETTER AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.9: LETTER AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.10: LETTER AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.11: LETTER AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.12: CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.13: CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.14: CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.15: CONSULTING AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.16: LETTER AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.17: FORM OF DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.18: LETTER AGREEMENT (Filed With SEC on March 30, 2007)

EX-10.19: LETTER AGREEMENT (Filed With SEC on June 19, 2006)

EX-4.2: SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 17, 2006)

EX-4.3: WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on May 17, 2006)

EX-10.1: 2002 EQUITY INCENTIVE PLAN , AS AMENDED (Filed With SEC on May 17, 2006)

EX-10.2: 2006 EQUITY INCENTIVE PLAN (Filed With SEC on May 17, 2006)

EX-10.3: 2006 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 17, 2006)

EX-10.4: LICENSE AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.5: LICENSE AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.6: EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.7: SUBLEASE AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.8: AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.9: LETTER AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.10: LETTER AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.11: LETTER AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.12: LETTER AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.13: CHANGE IN CONTROL AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.14: CHANGE IN CONTROL AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.15: CHANGE IN CONTROL AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.16: CONSULTING AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.17: LETTER AGREEMENT (Filed With SEC on May 17, 2006)

EX-10.18: FORM OF DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on May 17, 2006)

Category

Industry

Companies

Contracts

AMICUS THERAPEUTICS, INC. Contracts & Agreements